APP and cerebral amyloid angiopathy: Lewis TL et al. [112] designed an APP/PS1/APOA-I triple transgenic mice model and found that overexpressing the APOA-I gene significantly alleviates cerebral amyloid angiopathy (CAA) pathology and microglia activation.